Evidence map›Paper›PMID 40512388›Full record

ReviewApplied microbiology and biotechnology2025

Recent fermentation developments for improved rhamnolipid production.

Phavit Wongsirichot, James Winterburn

Abstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Phavit WongsirichotDepartment of Chemical Engineering, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
James WinterburnDepartment of Chemical Engineering, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK. james.winterburn@manchester.ac.uk.

Funding

Engineering and Physical Sciences Research Council EP/X038181/1
6 · The paper itself

Abstract

Rhamnolipids (RL) are microbial amphiphilic molecules containing a hydrophilic rhamnose head and a hydrophobic fatty acid tail. RL are of interest to academia and industry due to their potential as a biosurfactant, being used to substitute petroleum-based surfactants in traditional applications or in novel bioremediation and biomedical applications. Currently, commercialization of RL is still in a nascent state, and improved RL production in terms of titers, yields, and productivities could benefit their techno-economic viability and market competitiveness. This review provides a detailed assessment of recent studies that have achieved higher RL production through improvements in microbial producers, media formulation, fermentation design, and operations. Key successes and areas for future work are identified and discussed in detail, as well as put into context with pilot-scale and techno-economic analysis of RL production from the wider literature. This review provides an updated perspective on the current status of RL production. The discussions and insights provided could potentially be used to improve future RL and biosurfactant commercialization efforts.

Indexed as

BacteriaFermentationGlycolipidsBiotechnologyCulture MediaSurface-Active AgentsCulture MediaGlycolipidsrhamnolipidSurface-Active AgentsBiosurfactantsFermentationHigh productivityProcess developmentRhamnolipids

Identifiers

PMID40512388
PMCPMC12165997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.